'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% storm
The Economic Times has reported a new India-focused foreign affairs development: “'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% storm.” The publisher's feed describes the story as follows: US Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly after August 1, 2026, impacting imports. The issue was not raised during his discussions with India's External Affairs Minister S Jaishanka
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


